Investigating how a protein affects brain development and myelination.
Role of DYT6 Dystonia Protein THAP1 in Oligodendroglial Mediated ECM Homeostasis During CNS Development
['FUNDING_R01'] · CASE WESTERN RESERVE UNIVERSITY · NIH-10863834
This study is looking at how a protein called THAP1 helps shape the brain's support structure during development, which is important for healthy nerve function, and it aims to find out how this might relate to DYT6 dystonia, so that we can better understand and help those affected by this condition.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | CASE WESTERN RESERVE UNIVERSITY (nih funded) |
| Locations | 1 site (CLEVELAND, UNITED STATES) |
| Trial ID | NIH-10863834 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding the role of the THAP1 protein in the brain's extracellular matrix (ECM) during central nervous system (CNS) development. It aims to uncover how oligodendrocyte progenitor cells (OPCs) contribute to ECM composition, which is crucial for myelination and synaptic plasticity. By utilizing advanced techniques like ChIP-seq and transcriptomic studies, the research will explore the molecular mechanisms that regulate ECM and myelination, particularly in the context of DYT6 dystonia. Patients may benefit from insights into how disruptions in these processes could lead to neurodevelopmental disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with DYT6 dystonia or related neurodevelopmental disorders, particularly those under 21 years old.
Not a fit: Patients with conditions unrelated to myelination or ECM dysfunction may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for neurodevelopmental disorders related to myelination and synaptic function.
How similar studies have performed: While the specific role of THAP1 in ECM regulation is a novel approach, previous studies have shown success in understanding myelination and ECM interactions in other contexts.
Where this research is happening
CLEVELAND, UNITED STATES
- CASE WESTERN RESERVE UNIVERSITY — CLEVELAND, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: YELLAJOSHYULA, DHANANJAY — CASE WESTERN RESERVE UNIVERSITY
- Study coordinator: YELLAJOSHYULA, DHANANJAY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.